IRONWOOD PHARMACEUTICALS INC (IRWD) › Capital ExpendituresIRONWOOD PHARMACEUTICALS INC (IRWD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $3.52M2010: $17.22M2011: $9.68M2012: $13.98M2013: $9.59M2014: $3.54M2015: $4.05M2016: $4.21M2017: $2.80M2018: $351.0K2019: $7.19M2020: $1.84M2021: $265.0K2022: $136.0K2023: $273.0K2024: $142.0K2025: $34.0K$34.0K2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$34.0K-76.1%2024$142.0K-48.0%2023$273.0K+100.7%2022$136.0K-48.7%2021$265.0K-85.6%2020$1.84M-74.4%2019$7.19M+1948.1%2018$351.0K-87.5%2017$2.80M-33.4%2016$4.21M+3.9%2015$4.05M+14.4%2014$3.54M-63.1%2013$9.59M-31.4%2012$13.98M+44.4%2011$9.68M-43.8%2010$17.22M+388.6%2009$3.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share